Lytix Biopharma appoints Stephen Worsley as Chief Business Officer ...Middle East

PR Newswire - News
OSLO, Norway, Sept. 5, 2022 /PRNewswire/ -- Lytix Biopharma ("Lytix") (Euronext Growth Oslo: LYTIX), a Norwegian immune-oncology company, today announces the appointment of Stephen Worsley as Chief Business Officer (CBO). Stephen Worsley is a pharmaceutical executive with over 25 years of...

Hence then, the article about lytix biopharma appoints stephen worsley as chief business officer was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Lytix Biopharma appoints Stephen Worsley as Chief Business Officer )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News